HIV-associated lipodystrophy
Results: 2
| # | Item |
|---|---|
1![PRIOR AUTHORIZATION POLICY Egrifta™ (tesamorelin injection – EMD Serono) To initiate a Coverage Review, Call[removed]OVERVIEW Egrifta is an analog of human growth hormone-releasing factor (GRF), indicated for](https://www.pdfsearch.io/img/3ef1b8d22edf60b86ec3d525c1087101.jpg "PRIOR AUTHORIZATION POLICY Egrifta™ (tesamorelin injection – EMD Serono) To initiate a Coverage Review, Call[removed]OVERVIEW Egrifta is an analog of human growth hormone-releasing factor (GRF), indicated for") | PRIOR AUTHORIZATION POLICY Egrifta™ (tesamorelin injection – EMD Serono) To initiate a Coverage Review, Call[removed]OVERVIEW Egrifta is an analog of human growth hormone-releasing factor (GRF), indicated forAdd to Reading ListSource URL: statehealthplan.state.nc.usLanguage: English - Date: 2013-10-03 14:58:53 |
2 | Microsoft Word - PIN3418_lipodystrophy_v1.docAdd to Reading ListSource URL: www.cuh.org.ukLanguage: English - Date: 2014-03-07 12:25:49 |